Legal & General Group PLC Rapt Therapeutics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 2,379 shares of RAPT stock, worth $2,640. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,379

Previous 2,379 -0.0%

Holding current value

$2,640

Previous $4,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.89 - $9.38 $39,705 - $128,871	-13,739 Reduced 85.24%	2,379 $7,000
Q1 2024 May 14, 2024	SELL	$6.87 - $26.45 $33,312 - $128,256	-4,849 Reduced 23.13%	16,118 $144,000
Q4 2023 Feb 15, 2024	SELL	$11.28 - $25.46 $902 - $2,036	-80 Reduced 0.38%	20,967 $521,000
Q3 2023 Nov 14, 2023	BUY	$16.34 - $24.66 $19,836 - $29,937	1,214 Added 6.12%	21,047 $349,000
Q2 2023 Aug 14, 2023	BUY	$16.06 - $21.61 $122,168 - $164,387	7,607 Added 62.22%	19,833 $370,000
Q1 2023 May 15, 2023	BUY	$17.19 - $30.8 $33,486 - $59,998	1,948 Added 18.95%	12,226 $224,000
Q4 2022 Feb 14, 2023	BUY	$16.28 - $24.6 $20,643 - $31,192	1,268 Added 14.07%	10,278 $203,000
Q3 2022 Nov 14, 2022	BUY	$17.96 - $30.46 $9,788 - $16,600	545 Added 6.44%	9,010 $217,000
Q2 2022 Aug 22, 2022	BUY	$10.26 - $23.59 $14,128 - $32,483	1,377 Added 19.43%	8,465 $155,000
Q1 2022 May 16, 2022	SELL	$17.02 - $40.22 $391 - $925	-23 Reduced 0.32%	7,088 $156,000
Q4 2021 Feb 14, 2022	BUY	$29.5 - $39.5 $1,327 - $1,777	45 Added 0.64%	7,111 $261,000
Q3 2021 Nov 15, 2021	BUY	$29.86 - $39.47 $120,007 - $158,629	4,019 Added 131.9%	7,066 $220,000
Q2 2021 Aug 12, 2021	BUY	$17.99 - $40.02 $11,747 - $26,133	653 Added 27.28%	3,047 $96,000
Q1 2021 May 17, 2021	BUY	$16.0 - $24.46 $16,880 - $25,805	1,055 Added 78.79%	2,394 $53,000
Q3 2020 Nov 13, 2020	SELL	$21.6 - $37.5 $10,130 - $17,587	-469 Reduced 25.94%	1,339 $43,000
Q2 2020 Aug 14, 2020	BUY	$14.16 - $32.85 $21,820 - $50,621	1,541 Added 577.15%	1,808 $52,000
Q4 2019 Feb 13, 2020	BUY	$12.3 - $30.78 $3,284 - $8,218	267 New	267 $7,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $32.9M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Rapt Therapeutics, Inc. Transaction History